A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
The search for a universal filovirus vaccine that provides protection against multiple filovirus species has been prompted by sporadic but highly lethal outbreaks of Ebolavirus and Marburgvirus infections. A good prophylactic vaccine should be able to provide protection to all known filovirus specie...
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5819775?pdf=render |
id |
doaj-1c9268dfcf4a4e8a82c62cc9e22464aa |
---|---|
record_format |
Article |
spelling |
doaj-1c9268dfcf4a4e8a82c62cc9e22464aa2020-11-25T00:40:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01132e019231210.1371/journal.pone.0192312A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.Benoit CallendretJort VellingaKerstin WunderlichAriane RodriguezRobin SteigerwaldUlrike DirmeierCedric CheminayAriane VolkmannTrevor BraselRicardo CarrionLuis D GiavedoniJean L PattersonChad E MireThomas W GeisbertJay W HooperMo WeijtensJutta Hartkoorn-PasmaJerome CustersMaria Grazia PauHanneke SchuitemakerRoland ZahnThe search for a universal filovirus vaccine that provides protection against multiple filovirus species has been prompted by sporadic but highly lethal outbreaks of Ebolavirus and Marburgvirus infections. A good prophylactic vaccine should be able to provide protection to all known filovirus species and as an upside potentially protect from newly emerging virus strains. We investigated the immunogenicity and protection elicited by multivalent vaccines expressing glycoproteins (GP) from Ebola virus (EBOV), Sudan virus (SUDV), Taï Forest virus (TAFV) and Marburg virus (MARV). Immune responses against filovirus GP have been associated with protection from disease. The GP antigens were expressed by adenovirus serotypes 26 and 35 (Ad26 and Ad35) and modified Vaccinia virus Ankara (MVA) vectors, all selected for their strong immunogenicity and good safety profile. Using fully lethal NHP intramuscular challenge models, we assessed different vaccination regimens for immunogenicity and protection from filovirus disease. Heterologous multivalent Ad26-Ad35 prime-boost vaccination regimens could give full protection against MARV (range 75%-100% protection) and EBOV (range 50% to 100%) challenge, and partial protection (75%) against SUDV challenge. Heterologous multivalent Ad26-MVA prime-boost immunization gave full protection against EBOV challenge in a small cohort study. The use of such multivalent vaccines did not show overt immune interference in comparison with monovalent vaccines. Multivalent vaccines induced GP-specific antibody responses and cellular IFNγ responses to each GP expressed by the vaccine, and cross-reactivity to TAFV GP was detected in a trivalent vaccine expressing GP from EBOV, SUDV and MARV. In the EBOV challenge studies, higher humoral EBOV GP-specific immune responses (p = 0.0004) were associated with survival from EBOV challenge and less so for cellular immune responses (p = 0.0320). These results demonstrate that it is feasible to generate a multivalent filovirus vaccine that can protect against lethal infection by multiple members of the filovirus family.http://europepmc.org/articles/PMC5819775?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Benoit Callendret Jort Vellinga Kerstin Wunderlich Ariane Rodriguez Robin Steigerwald Ulrike Dirmeier Cedric Cheminay Ariane Volkmann Trevor Brasel Ricardo Carrion Luis D Giavedoni Jean L Patterson Chad E Mire Thomas W Geisbert Jay W Hooper Mo Weijtens Jutta Hartkoorn-Pasma Jerome Custers Maria Grazia Pau Hanneke Schuitemaker Roland Zahn |
spellingShingle |
Benoit Callendret Jort Vellinga Kerstin Wunderlich Ariane Rodriguez Robin Steigerwald Ulrike Dirmeier Cedric Cheminay Ariane Volkmann Trevor Brasel Ricardo Carrion Luis D Giavedoni Jean L Patterson Chad E Mire Thomas W Geisbert Jay W Hooper Mo Weijtens Jutta Hartkoorn-Pasma Jerome Custers Maria Grazia Pau Hanneke Schuitemaker Roland Zahn A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. PLoS ONE |
author_facet |
Benoit Callendret Jort Vellinga Kerstin Wunderlich Ariane Rodriguez Robin Steigerwald Ulrike Dirmeier Cedric Cheminay Ariane Volkmann Trevor Brasel Ricardo Carrion Luis D Giavedoni Jean L Patterson Chad E Mire Thomas W Geisbert Jay W Hooper Mo Weijtens Jutta Hartkoorn-Pasma Jerome Custers Maria Grazia Pau Hanneke Schuitemaker Roland Zahn |
author_sort |
Benoit Callendret |
title |
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. |
title_short |
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. |
title_full |
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. |
title_fullStr |
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. |
title_full_unstemmed |
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. |
title_sort |
prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with ebolavirus and marburgvirus species in non-human primates. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2018-01-01 |
description |
The search for a universal filovirus vaccine that provides protection against multiple filovirus species has been prompted by sporadic but highly lethal outbreaks of Ebolavirus and Marburgvirus infections. A good prophylactic vaccine should be able to provide protection to all known filovirus species and as an upside potentially protect from newly emerging virus strains. We investigated the immunogenicity and protection elicited by multivalent vaccines expressing glycoproteins (GP) from Ebola virus (EBOV), Sudan virus (SUDV), Taï Forest virus (TAFV) and Marburg virus (MARV). Immune responses against filovirus GP have been associated with protection from disease. The GP antigens were expressed by adenovirus serotypes 26 and 35 (Ad26 and Ad35) and modified Vaccinia virus Ankara (MVA) vectors, all selected for their strong immunogenicity and good safety profile. Using fully lethal NHP intramuscular challenge models, we assessed different vaccination regimens for immunogenicity and protection from filovirus disease. Heterologous multivalent Ad26-Ad35 prime-boost vaccination regimens could give full protection against MARV (range 75%-100% protection) and EBOV (range 50% to 100%) challenge, and partial protection (75%) against SUDV challenge. Heterologous multivalent Ad26-MVA prime-boost immunization gave full protection against EBOV challenge in a small cohort study. The use of such multivalent vaccines did not show overt immune interference in comparison with monovalent vaccines. Multivalent vaccines induced GP-specific antibody responses and cellular IFNγ responses to each GP expressed by the vaccine, and cross-reactivity to TAFV GP was detected in a trivalent vaccine expressing GP from EBOV, SUDV and MARV. In the EBOV challenge studies, higher humoral EBOV GP-specific immune responses (p = 0.0004) were associated with survival from EBOV challenge and less so for cellular immune responses (p = 0.0320). These results demonstrate that it is feasible to generate a multivalent filovirus vaccine that can protect against lethal infection by multiple members of the filovirus family. |
url |
http://europepmc.org/articles/PMC5819775?pdf=render |
work_keys_str_mv |
AT benoitcallendret aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT jortvellinga aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT kerstinwunderlich aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT arianerodriguez aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT robinsteigerwald aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT ulrikedirmeier aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT cedriccheminay aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT arianevolkmann aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT trevorbrasel aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT ricardocarrion aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT luisdgiavedoni aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT jeanlpatterson aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT chademire aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT thomaswgeisbert aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT jaywhooper aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT moweijtens aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT juttahartkoornpasma aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT jeromecusters aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT mariagraziapau aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT hannekeschuitemaker aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT rolandzahn aprophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT benoitcallendret prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT jortvellinga prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT kerstinwunderlich prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT arianerodriguez prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT robinsteigerwald prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT ulrikedirmeier prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT cedriccheminay prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT arianevolkmann prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT trevorbrasel prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT ricardocarrion prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT luisdgiavedoni prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT jeanlpatterson prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT chademire prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT thomaswgeisbert prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT jaywhooper prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT moweijtens prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT juttahartkoornpasma prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT jeromecusters prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT mariagraziapau prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT hannekeschuitemaker prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates AT rolandzahn prophylacticmultivalentvaccineagainstdifferentfilovirusspeciesisimmunogenicandprovidesprotectionfromlethalinfectionswithebolavirusandmarburgvirusspeciesinnonhumanprimates |
_version_ |
1725291105288716288 |